ABSCI CORP
ABSINASDAQπ #2135 by market capEarnings Mar 23US Equity
$7.51βΌ $0.65 (β7.97%)
Market closed Β· at closeTrack ABSI
Get earnings, price moves & breaking news on Telegram
24hβΌ 8.0%
7dβΌ 11.1%
14dβΌ 26.2%
30dβΌ 18.1%
ytdβ² 115.5%
1yβ² 155.4%
π¦Market Cap
$1.29B
Small Cap
πRevenue Growth (YoY)
-62.3%
Declining
πGross Margin
β
π΅FCF Margin
β
βοΈP/S Ratio
831.1x
Expensive
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $7.45 β $8.13
- 52-Week Range
- $2.24 β $12.54
- Volume (shares)
- 4,747,472
- Avg Volume (shares)
- β
- Shares Outstanding
- 171.6M
- Next Earnings
- 2027-03-23
Fundamentals Snapshot
- Annual Revenue
- $3M
- Last Q Revenue
- $304,000
- P/E Ratio
- β
- P/S Ratio
- 831.1x
- EPS (TTM)
- $-0.80
- Dividend Yield
- β
- Dilution (1yr)
- +31.0%
ABSCI CORP
ABSIFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3MβΌ β38.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-319.4%βΌ β75.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$125Mβ² +14.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$94Mβ² +29.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
150.6Mβ² +31.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$15MβΌ β$16M YoY
About ABSCI CORP
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
β‘Momentumβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst data unavailable.
Latest News & Updates
News unavailable.